Filing Flows › Guardian Pharmacy Services (GRDN) › Q2 2026 › vs Q2 2025
Guardian Pharmacy Services (GRDN) Q2 2026 vs Q2 2025 (year over year)
Guardian Pharmacy Services's revenue rose $7.4M (+2%) from $344M in Q2 2025 to $352M in Q2 2026. Gross margin 22.8% against 19.8% (+3.0 pts).
Guardian Pharmacy Services, Q2 2026: revenue $352M (+2% year over year), operating margin 5.9%, net earnings $22.1M, operating cash flow $30.0M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 22.8% | 19.8% | +3.0 pts |
| Operating margin | 5.9% | 3.7% | +2.2 pts |
| Net margin | 6.3% | 2.6% | +3.7 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $352M | $344M | $7.4M | +2% |
| Gross profit | $80.0M | $68.1M | $11.9M | +17% |
| Cost of revenue | $272M | $276M | −$4.5M | -2% |
| Other income, net | $9.1M | $7K | $9.1M | 1,307× |
| Operating profit | $20.6M | $12.6M | $8.1M | +64% |
| Operating expenses | $59.4M | $55.6M | $3.8M | +7% |
| Pre-tax earnings | $29.8M | $12.6M | $17.2M | +137% |
| Net earnings | $22.1M | $8.8M | $13.3M | +151% |
| Income tax | $7.7M | $3.8M | $3.9M | +104% |
| Depreciation & amortization | $5.8M | $5.5M | $319K | +6% |
| Share-based compensation | $2.9M | $4.4M | −$1.5M | -34% |
| Working capital & other | $836K | −$1.2M | $2.0M | — |
| Operating cash flow | $30.0M | $19.9M | $10.1M | +51% |
Questions
How much did Guardian Pharmacy Services's revenue grow year over year in Q2 2026?
Guardian Pharmacy Services's revenue rose $7.4M (+2%) from $344M in Q2 2025 to $352M in Q2 2026. Gross margin 22.8% against 19.8% (+3.0 pts).